Public Policy & Prov Affairs Lead - Ontario at Bristol-Myers Squibb

Canelones, Uruguay

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

University degree (life science or business)
A medical or pharmacy degree would be an asset
Five to seven years of field market access, policy and stakeholder engagement experience
Prior work experience in government affairs would be an asset
Proven track record in securing market access and advancing policy/health system changes in region
Successful experience in the bio-pharmaceutical / life-sciences industry engaging and negotiating with external stakeholders
Expected to reside in Ontario to facilitate the majority of stakeholder engagement activities
~60% of time is expected in external engagement activities
Travel requirements 20% of time or less

Responsibilities

Design and implement provincial policy and access plans, including health system implementation considerations, aligned with Market Access and Brand plans to ensure overall business objectives are met
Prepare the health policy and disease area landscape for timely access and adoption of BMS pipeline priorities, with the ambition of access at regulatory approval, while working closely with Early Asset / Brand Leads and Market Access
Co-create health system solutions with provincial partners to overcome access barriers and ensure appropriate, timely access for patients
Gain and maintain market access to BMS products by securing timely and seamless funding on public and private drug programs in Ontario
Engage and partner, where appropriate, with ecosystem stakeholders (government, health system stewards, professional associations, etc.) to move forward key policy priorities
Participate in trade association / life-science working groups to foster collaboration, advance BMS perspectives and industry positions on key policy issues
Negotiate with Private and Public Drug programs in Ontario and other provincial health authorities, securing timely patient access that recognizes the value of pharmaceutical innovations
Act as a subject matter expert on provincial policy matters, reimbursement pathways and health system specifications; playing a leadership role within the Canadian team to ensure corporate objectives are met

Skills

Public Policy

Market Access

Health Policy

Stakeholder Engagement

Strategic Planning

Health System Integration

Regulatory Approval

Pipeline Management

Brand Strategy

Access Plans

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free